XML 40 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Mar. 31, 2015
STOCKHOLDERS' EQUITY [Abstract]  
Schedule of Stock Option Activity


 Nine months ended March 31, 2015 (Unaudited)            
     Number      Weighted Average
Exercise Price
     Weighted Average
Remaining
Contractual Terms
(in years)
     Aggregate Intrinsic
Value Price
Options outstanding at beginning of period     1,862,099     $ 3.73                
Options exercised     (8,000 )   $ 0.88                
Options forfeited     (423   $ 4.40                
Options outstanding at end of the period     1,853,676     $ 3.74       2.37     $ 895
Options exercisable at the end of the period     1,853,676     $ 3.74       2.37     $ 895
Options vested     1,853,676     $ 3.74       2.37     $ 895
Schedule of Stock Option and Warrant Activity
   Nine months ended March 31, 2015 (Unaudited)           

   Number      Weighted 
Average

Exercise Price
     Weighted
Average
Remaining
Contractual
Terms 
(in years)
     Aggregate
 Intrinsic 
Value 
Price
Options and warrants outstanding at beginning of period     252,000     $ 5.19                
Options granted     1,000     $ 0.00001                  
Options and warrants outstanding at end of the period     253,000     $ 5.17       3.23     $ 297
                               
Options and warrants exercisable at the end of the period     252,000     $ 5.19       3.21     $ 294
                               
Options and warrants vested and expected to vest     253,000     $ 5.17       3.23     $ 297
Options and warrants [Member]  
Stockholders Equity Note [Line Items]  
Schedule of Stock-based Compensation Expenses
Nine months ended March 31, Three months ended March  31,
2015 2014 2015   2014
Research and development expenses   $ 1     $ 7   $          -     $             7
General and administrative expenses   1       -   1       -
    $ 2     $ 7   $          1     $             7
Restricted stock units [Member]  
Stockholders Equity Note [Line Items]  
Schedule of Unvested Restricted Stock Units
  Number  
Unvested at the beginning of period 1,589,432  
Granted 1,028,153  
Forfeited (22,676 )
Vested (1,021,757 )
Unvested at the end of the period 1,573,152  
Expected to vest after March 31, 2015 1,510,189  
Schedule of Stock-based Compensation Expenses
Nine months ended March 31, Three months ended March 31,
     2015      2014      2015      2014
Research and development expenses   $ 977     $ 656     $ 482     $ 442
General and administrative expenses     1,735       3,299       592       1,196
    $ 2,712     $ 3,955     $ 1,074     $ 1,638
Consultant restricted stock units [Member]  
Stockholders Equity Note [Line Items]  
Schedule of Unvested Restricted Stock Units
  Number  
Unvested at the beginning of period 15,250  
Granted 70,180  
Forfeited -  
Vested (69,805 )
Unvested at the end of the period 15,625  
Expected to vest after March 31, 2015 15,625  
Schedule of Stock-based Compensation Expenses
Nine months ended March 31, Three months ended  March 31,
2015 2014 2015   2014
Research and development expenses   $ 110     $ 59     $ 33     $ 42
General and administrative expenses     88       157       50     157
    $ 198     $ 216     $ 83     $ 199